Crystallographic and biochemical studies revealing the structural basis for antizyme inhibitor function
about
Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastomaEvolution of Substrate Specificity within a Diverse Family of / -Barrel-fold Basic Amino Acid Decarboxylases: X-RAY STRUCTURE DETERMINATION OF ENZYMES WITH SPECIFICITY FOR L-ARGININE AND CARBOXYNORSPERMIDINEStructural Insight into DFMO Resistant Ornithine Decarboxylase from Entamoeba histolytica: An Inkling to Adaptive EvolutionAntizyme inhibitor 1: a potential carcinogenic moleculeBiochemical, mutational and in silico structural evidence for a functional dimeric form of the ornithine decarboxylase from Entamoeba histolyticaStructural and degradative aspects of ornithine decarboxylase antizyme inhibitor 2.Non-synonymous single-nucleotide polymorphisms associated with blood pressure and hypertension.VASCo: computation and visualization of annotated protein surface contacts.Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation.The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationCritical factors governing the difference in antizyme-binding affinities between human ornithine decarboxylase and antizyme inhibitor.Minimal antizyme peptide fully functioning in the binding and inhibition of ornithine decarboxylase and antizyme inhibitor.Functional roles of the dimer-interface residues in human ornithine decarboxylase.Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer.Knockdown of ornithine decarboxylase antizyme 1 causes loss of uptake regulation leading to increased N1, N11-bis(ethyl)norspermine (BENSpm) accumulation and toxicity in NCI H157 lung cancer cells.Structural basis of antizyme-mediated regulation of polyamine homeostasis.Multifaceted interactions and regulation between antizyme and its interacting proteins cyclin D1, ornithine decarboxylase and antizyme inhibitor.Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.Mammalian polyamine metabolism and functionCritical factors determining dimerization of human antizyme inhibitor.Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma.Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor.Polyamines: therapeutic perspectives in oxidative stress and inflammatory diseases.Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma.FRETex: a FRET-based, high-throughput technique to analyze protein-protein interactions.Myc, Oncogenic Protein Translation, and the Role of Polyamines.
P2860
Q26770306-49BE0A6B-B27A-43EB-BE29-15742AF43C7AQ27662159-50C0743C-35B7-4CD2-BB63-C6BB76B4C31AQ27675929-5E74C219-D7F5-4A4F-8B33-B5A3BC89F689Q28074076-0DF3A6EA-CEDD-4AB9-808D-A0E65EF68ED2Q28481304-2BD1D2C8-CDDB-4D17-BC19-D9EC33AC27F9Q29347303-D136230A-AB20-4B20-AB90-BEC82970A82FQ30385528-ADBC3B6B-ACF9-4FAF-B07A-E06810421868Q30486213-98012081-FD2B-4268-8BBE-156FC9F2E2D4Q33578405-1CC02FF1-824B-402B-99D1-C594B036F68BQ33761692-BFDF677C-E5F9-4290-8424-45B92F5AAB1DQ33892549-018C47DB-9978-4519-B0C9-2AE23B2E9666Q34023433-3E8C0279-8554-4E13-B8FD-30B56B80720FQ34070766-FE96957E-B006-4986-9D2E-36F365B9BA1DQ35386279-4D56CCB6-53F1-40DF-B2C1-B5408A26F5E0Q35618959-1A346660-B6E7-4128-A829-1F7F07B5F47EQ36056787-01695561-ED14-4BCF-8577-00C5AEDB5EEFQ36414339-8DC828C1-C3C8-4C5F-9F3B-930202CE9123Q37198014-3558F2B9-951D-4C6F-86EF-47885E2AB046Q37365983-442F935B-4EC6-49AF-9DBD-539E7E17D6A3Q37446803-DCB56484-9AAB-438D-A6BB-C9FC0E27DBEEQ37605450-0761176F-5358-40F3-91EB-472B0AD7EDB1Q37679977-8C2C22E2-79A6-42D2-B0C8-DC9B1276B22EQ38653424-DD1F8DD0-AFC4-4A2D-A8FC-E2E0FCF22346Q41107342-8E6A1755-C172-4F34-9594-DC0553C171A8Q45905608-125E5E72-9A1F-41DF-BD87-675D6701D677Q55414287-3CE94173-F7F4-44AD-AD18-523389E2C418
P2860
Crystallographic and biochemical studies revealing the structural basis for antizyme inhibitor function
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Crystallographic and biochemic ...... or antizyme inhibitor function
@ast
Crystallographic and biochemic ...... or antizyme inhibitor function
@en
Crystallographic and biochemic ...... or antizyme inhibitor function
@nl
type
label
Crystallographic and biochemic ...... or antizyme inhibitor function
@ast
Crystallographic and biochemic ...... or antizyme inhibitor function
@en
Crystallographic and biochemic ...... or antizyme inhibitor function
@nl
prefLabel
Crystallographic and biochemic ...... or antizyme inhibitor function
@ast
Crystallographic and biochemic ...... or antizyme inhibitor function
@en
Crystallographic and biochemic ...... or antizyme inhibitor function
@nl
P2093
P2860
P356
P1433
P1476
Crystallographic and biochemic ...... or antizyme inhibitor function
@en
P2093
Chaim Kahana
Shira Albeck
Tamar Unger
Zippy Bercovich
Zohar Snapir
P2860
P304
P356
10.1110/PS.073427208
P577
2008-05-01T00:00:00Z